Status:

TERMINATED

Visual Enhancement Device in Low Vision Patients

Lead Sponsor:

University of Texas Southwestern Medical Center

Conditions:

Macular Degeneration, Age-Related

Diabetic Retinopathy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will be a prospective, non-randomized study of low-vision individuals diagnosed with either age-related macular degeneration (AMD) or diabetic macular edema with ETDRS visual acuity from 20...

Detailed Description

A single visit, prospective, non-randomized study of low vision individuals diagnosed with Age Related Macular Degeneration or Diabetic macular edema research project is designed to last about 1.5 hou...

Eligibility Criteria

Inclusion

  • Patient of any sex, race, or ethnicity who are 18 years of age or older. Spanish speaking patients will be encouraged to participate, Spanish forms will be available to review and execute.
  • Patient willing to review, understand and sign written informed consent. Parents or legal guardians will consent on behalf of minors.
  • Written authorization for use or release of health and research study information.
  • Patient who volunteers is suffering from a posterior segment ophthalmic disorder including AMD and/or Diabetic Retinopathy and visual acuity from 20/60 to 20/400 in the better seeing eye.

Exclusion

  • Subjects will be excluded if they are less than 18 years of age.
  • Subjects will not be considered for this research study if they will not review and execute the informed consent form.
  • During the screening process, subjects will be excluded from further consideration if they are identified with having a potential ophthalmic diagnosis other than age-related macular degeneration or diabetic macular edema that could be negatively affecting the visual testing.
  • ETDRS Visual Acuity better than 20/60 or worse than 20/400
  • During screening, subjects will be disqualified from further assessment if it is determined that their refractive error is outside of the -5.00 to +5.00 D corrective range.

Key Trial Info

Start Date :

February 1 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 28 2018

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT03794752

Start Date

February 1 2015

End Date

December 28 2018

Last Update

January 5 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.